Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Gastrointestinal Motility Disorder: early-phase trial registry
2 of 3 indexed Gastrointestinal Motility Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Gastrointestinal Motility Disorder: 3 US clinical trials tracked, 2 recruiting.
Gastrointestinal Motility Disorder is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Motus Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition gastrointestinal-motility-disorder
OPEN 2 | RECR 67% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Gastrointestinal Motility Disorder lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Gastrointestinal Motility Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Gastrointestinal Motility Disorder is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
University of Louisville
NCT04208828
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
The University of Texas Health Science Center, Houston
NCT05989763
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
Motus Therapeutics
NCT01394055
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Gastrointestinal Motility Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Gastrointestinal Motility Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Gastrointestinal Motility Disorder page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Gastrointestinal Motility Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Motus Therapeutics sponsors the most Gastrointestinal Motility Disorder trials on record, review their full trial history before evaluating a specific study. See Motus Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gastrointestinal Motility Disorder condition card totals 3 registered trials; most-linked intervention RM-131; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.